rs372082751
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_002878.4(RAD51D):c.4G>T(p.Gly2Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000000685 in 1,458,912 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002878.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000406 AC: 1AN: 246552Hom.: 0 AF XY: 0.00000747 AC XY: 1AN XY: 133780
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1458912Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 725926
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
This variant is denoted RAD51D c.4G>T at the cDNA level, p.Gly2Cys (G2C) at the protein level, and results in the change of a Glycine to a Cysteine (GGC>TGC). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. RAD51D Gly2Cys was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, suggesting it is not a common benign variant in these populations. Since Glycine and Cysteine differ in polarity, charge, size or other properties, this is considered a non-conservative amino acid substitution. RAD51D Gly2Cys occurs at a position where amino acids with properties similar to Glycine are tolerated across species and is located in the region that preferentially binds ssDNA (Kim 2011, UniProt). In silico analyses are inconsistent regarding the effect this variant may have on protein structure and function. This variant occurs in a conserved nucleotide in the Kozak consensus sequence and therefore may impact protein translation; however, in the absence of functional studies, the actual effect of this variant is unknown. Based on currently available evidence, it is unclear whether RAD51D Gly2Cys is pathogenic or benign. We consider it to be a variant of uncertain significance. -
Breast-ovarian cancer, familial, susceptibility to, 4 Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 2 of the RAD51D protein (p.Gly2Cys). This variant is present in population databases (rs372082751, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with RAD51D-related conditions. ClinVar contains an entry for this variant (Variation ID: 421161). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at